|Other Names||Valine--tRNA ligase, Protein G7a, Valyl-tRNA synthetase, ValRS, VARS, G7A, VARS2|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP7843c was selected from the Center region of human VARS. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. This protein belongs to class-I aminoacyl-tRNA synthetase family and is located in the class III region of the major histocompatibility complex.
Jiang,S., FEBS Lett. 579 (27), 6049-6054 (2005)Bonnefond,L., Biochemistry 44 (12), 4805-4816 (2005)Xie,T., Genome Res. 13 (12), 2621-2636 (2003)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.